SIG +1.92%: Sigma is a chemist retailer operating under brands like Amcal and they also have a large wholesale business, although smaller than it once was after losing the contract to supply Chemist Warehouse a few years ago. They released FY22 results today and presented to us this afternoon. We haven’t really looked at SIG before and find it hard to get excited about the stock right now, although it is in turnaround mode. Today’s result was in line with both guidance and market expectations, FY22 underlying EBITDA of $92.1m was +10.8% on last year and compared to guidance of +10-15%. No FY23 guidance, but expects to return to profit in the period.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Buy Hold Sell: The best and worst performers of FY25
Close
Friday 27th June – ASX +13pts, REH, BOE, IFL
Close
Friday 27th June – Dow up +404pts, SPI up +51pts
Close
MM has no real interest in SIG
Add To Hit List
Related Q&A
Question on SIG ( Sigma Health Care )
sigma/chemist warehouse reverse takeover
Thoughts on Sigma Healthcare (SIG)
sigma/ chemist warehouse reverse takeover
Sigma-Chemist Warehouse Merger
DMP & Chemist Warehouse
Sigma and Chemist Warehouse merger
What are MM’s thoughts on Sigma (SIG)?
Relevant suggested news and content from the site

Video
WATCH
Buy Hold Sell: The best and worst performers of FY25
James Gerrish & Henry Jennings

Podcast
LISTEN
Friday 27th June – ASX +13pts, REH, BOE, IFL
Daily Podcast Direct from the Desk

Podcast
LISTEN
Friday 27th June – Dow up +404pts, SPI up +51pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.